Eden vs ShedRx: GLP-1 Cost, Quality & Best Pick Compared

If your priority is the lowest advertised entry price on compounded semaglutide and a wide medication menu to choose from, Eden is the more natural starting point to price-check. If you want a more guided, program-style experience with included support touchpoints and you don't mind paying for that structure, ShedRx is worth the look. In practice the two are close enough on headline cost that the deciding factors are usually (1) which specific medication and dose your provider recommends, (2) which pharmacy would fill it, and (3) the fine print on membership and cancellation.

One thing both share: they are compounded-forward. That makes them relevant mainly to cash-pay shoppers who either don't have GLP-1 coverage or want to avoid the branded-drug price. If you have insurance that covers Wegovy or Zepbound, or you'd qualify for manufacturer-direct pricing, that path can be cheaper and uses an FDA-approved product — compare it first.

We evaluate platforms like Eden and ShedRx on the factors that actually change a patient's cost and experience: transparent monthly pricing (including what happens as a dose escalates), the medication menu and whether it's compounded or branded, the identity and licensure of the pharmacy that fills the prescription, the required clinical intake, the support model, and the cancellation/refund terms. We do not accept payment for placement, and we don't promise any particular result — only a licensed provider can determine whether a medication is appropriate for you.

Because both companies update pricing and offers frequently, we describe ranges and structure rather than quoting a single guaranteed number. Always confirm the live price on the provider's own checkout before enrolling.

Both Eden and ShedRx market compounded semaglutide at introductory monthly prices that have commonly fallen in the low-to-mid $100s per month range in their public promotions, with compounded tirzepatide priced higher. These are company-attributed figures and they move — promotional intro rates can step up after the first month or first few months, and the price you ultimately pay depends on dose. Verify the current price at each source before enrolling.

When you compare, normalize for the things that hide in the footnotes: Does the advertised price include shipping? Is it an introductory rate that increases later? Does it cover the dose your provider would actually prescribe (early titration doses are smaller than maintenance doses)? Is there a separate consultation or membership fee? A program that looks $20/month cheaper on the headline can cost more once a higher maintenance dose kicks in.

For context on the alternative: branded Wegovy and Zepbound carry much higher list prices, but manufacturer-direct cash programs (NovoCare for Wegovy, LillyDirect for Zepbound) and insurance coverage can change that math substantially. Those use FDA-approved finished drugs, which compounded products are not.

Eden and ShedRx both center their offerings on compounded semaglutide and tirzepatide — the same active ingredients found in brand-name GLP-1 drugs, but prepared by compounding pharmacies rather than the original manufacturers. This is the single most important fact to understand: compounded GLP-1 medications are not FDA-approved. The FDA approves the brand-name finished products (Wegovy and Ozempic for semaglutide; Zepbound and Mounjaro for tirzepatide), and that approval does not extend to compounded versions.

Both platforms route prescriptions to state-licensed compounding pharmacies they partner with. The specific pharmacy can vary by patient and state, and it matters: a legitimate program fills through a licensed pharmacy after a valid prescription from a licensed provider. Before you enroll, ask each company which pharmacy would fill your prescription and confirm it is state-licensed. Avoid any source that offers to ship medication without a prescription and consultation — that is a red flag, not a deal.

Both require an intake with a licensed provider before any prescription is written — typically an online health questionnaire and asynchronous or synchronous review. Where they differ is the wrap-around: ShedRx markets itself with a more program-style framing, emphasizing ongoing check-ins and support as part of the experience, while Eden leans toward a broad, price-forward menu with provider messaging. Neither difference is dramatic, and the real-world experience depends heavily on the individual clinician and your state.

If you value structured coaching, periodic check-ins, and a more hand-held cadence, weight that toward the program-style option. If you're an experienced, self-directed patient who mainly wants a clean prescription-and-refill pipeline at a low price, the leaner option may suit you. Either way, treat the included support as a convenience, not a substitute for your own primary-care relationship and lab monitoring.

We could verify that both Eden and ShedRx operate as telehealth platforms connecting patients to licensed providers and that both market compounded semaglutide and tirzepatide as cash-pay options. We could verify the general structure of their offerings (intake, prescription, partner-pharmacy fulfillment, subscription/membership billing).

We could not independently verify, and you should confirm directly: the exact current monthly price for the dose you'd be prescribed, whether an advertised rate is introductory and what it becomes afterward, the specific compounding pharmacy that would fill your prescription, and the precise cancellation and refund terms. We did not lab-test any medication and we make no claim about the quality of any specific compounded product. Pricing and offers from both companies change frequently — the figures here are company-attributed ranges, not guarantees.

Eden and ShedRx are two of many. If you're shopping the compounded-forward, price-first lane, it's worth also pricing providers like Henry Meds, Ivim Health, TrimRx, GobyMeds, and MEDVi, which operate in a similar telehealth-plus-compounded model. For a branded, FDA-approved path, look at manufacturer-direct programs — NovoCare (Wegovy) and LillyDirect (Zepbound) — and check your insurance first. Larger consumer telehealth brands such as Ro and Hims & Hers also offer GLP-1 programs and are worth a quick price comparison, though their model and medication menu differ. The right choice is the one that pairs an appropriate, legally prescribed medication with a price and support level that fit your situation.